Why Pet Health Is The Focus Of A New Biotech Sector

Source: Life Science Leader By Cathy Yarbrough, Contributing Editor Follow Me On Twitter @sciencematter For Aratana Therapeutics, 2016 was a banner year. The biotech company, founded in 2010, achieved FDA approvals for three of its 10 pipeline drugs. Last year the Kansas … Keep Reading